ClinicalTrials.gg
CompletedNCT04774354Updated Jul 7, 2026

POSSUM, P-POSSUM, Clinical Frailty Scale, Clinical Frailty Scale and Charlson's Comorbidity Index in Abdominal Surgery.

An observational study in Postoperative Complications, sponsored by Ángel Becerra-Bolaños, MD PhD. Completed at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-07.

Sponsored by Ángel Becerra-Bolaños, MD PhD · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
350
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 69 studies in Postoperative Complications with a site in Spain — 13 open to participants now, 15 under way, 1 of them phase 3. Postoperative Complications · Spain.

Enrollment
21st of 37
350 · median 400
Started
2021
with 6 others
Observational
37 of 69
4 open now
Registered
42nd of 69
by date
Lead sponsor
2 of 69
Ángel Becerra-Bolaños, MD PhD

Among the 69 studies in Postoperative Complications with a site in Spain, this one is the 21st largest by enrollment of the 37 observational ones that give a count, is one of 7 that started in 2021, is one of 37 observational ones, and was the 42nd registered.

Postoperative Complications

1,343 studies on the registry are indexed under Postoperative Complications; 314 are open to participants now.

Browse Postoperative Complications studies →

Open to participants now

13 of the 69 studies in Postoperative Complications with a site in Spain are open now. Recruiting first, the newest first:

8 more — sign in →

All 13 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 200 Postoperative Complications studies recruiting now, 126 (63%) set no upper age limit and 31 (16%) stop at 75 or younger; 24 take children under 18; 25 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 69 studies in Postoperative Complications with a site in Spain, or all of them as a file.
02

Study summary

Abdominal surgery represents the most frequent activity in the surgical block. Advances in surgical techniques and improvements in postoperative care imply the need for greater control of the surgical outcomes obtained and the comparison of results between services with the same characteristics with the help of assessment scales.

A prospective observational study will be carried out during 2021. All patients undergoing abdominal surgery will be included. Demographic variables, personal and surgical history, preoperative and intraoperative data, and variables related to surgery will be collected. At 30 days postoperatively, the clinical history of the patients will be reviewed and postoperative complications will be collected as well as the mortality that occurred. With these data, the POSSUM, the P-POSSUM, the Clinical Frailty Scale and the Charlson comorbidity index will be calculated.

Read the detailed description

Abdominal surgery represents the most frequent activity in the surgical block. Advances in surgical techniques and improvements in postoperative care imply the need for greater control of the surgical outcomes obtained and the comparison of results between services with the same characteristics with the help of assessment scales.

A prospective observational study will be carried out during 2021. All patients undergoing abdominal surgery will be included. Demographic variables, personal and surgical history, preoperative and intraoperative data, and variables related to surgery will be collected. At 30 days postoperatively, the clinical history of the patients will be reviewed and postoperative complications will be collected as well as the mortality that occurred. With these data, the POSSUM, the P-POSSUM and the Charlson comorbidity index will be calculated.

Once this data are collected, the following objectives will be met:

  • Validate the POSSUM and P-POSSUM systems in patients undergoing gastrointestinal surgery in our hospital, comparing the estimated morbidity and mortality with that observed 30 days after surgery.
  • Analyze the correlation of estimated morbidity and mortality of the POSSUM and P-POSSUM with respect to that observed in scheduled surgery vs. emergencies.
  • Analyze the correlation of estimated morbidity and mortality of POSSUM and P-POSSUM with respect to that observed in laparoscopic surgery vs. laparotomy
  • Establish the relationship and predictive ability of Clinical Frailty Scale and Charlson Comorbidity Index with respect to morbidity and mortality at 30
03

Conditions studied

  • Postoperative Complications

Keywords

  • postoperative complications
  • abdominal surgery
  • urgent surgery
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

A prospective observational study will be carried out in which all patients undergoing gastrointestinal surgery will be included, both scheduled and urgently.

At 30 days postoperatively, the clinical records of the patients will be reviewed in order to establish the incidence of morbidity and mortality.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All patients undergoing scheduled or urgent intervention for gastrointestinal surgery will be included in the study.

Exclusion criteria

Exclusion Criteria:

  • Patients operated under locoregional anesthesia.
  • Patients undergoing Major Ambulatory Surgery (CMA) regardless of postoperative destination (home or hospitalization floor).
  • Patients intervened on a scheduled basis in the afternoon shift
  • Patients who require surgery after the first 24 hours of hospital admission
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
350 participants (actual)
Patient registry
No

Groups and cohorts

  • Abdominal surgery

    POSSUM, the P-POSSUM, the Clinical frailty scale, and the Charlson comorbidity index will be calculated and compared to the outcomes obtained in our center.

    Diagnostic Test: POSSUM

Interventions

  • Diagnostic testPOSSUM

    These scales will be calculated and compared to the outcomes obtained in our center.

    Also known as: P-POSSUM, Charlson comorbidity index, Clinical frailty scale

06

What researchers measure

Primary outcomes

  1. Validate the POSSUM and P-POSSUM systems in patients undergoing gastrointestinal surgery

    To compare the estimated morbidity and mortality with that observed.

    Time frame: 30 days after surgery.

Secondary outcomes

  1. Analyze the correlation of estimated morbidity and mortality of the POSSUM and P-POSSUM with respect to that observed in scheduled surgery vs. emergencies.

    To compare the estimated morbidity and mortality with that observed.

    Time frame: 30 days after surgery.

  2. Analyze the correlation of estimated morbidity and mortality of POSSUM and P-POSSUM with respect to that observed in laparoscopic surgery vs. laparotomy

    To compare the estimated morbidity and mortality with that observed

    Time frame: 30 days after surgery.

07

Study locations

1 site
  • Ángel Becerra
    Las Palmas de Gran Canaria, Las Palmas 35019, Spain
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2021 to primary completion in Mar 2025, 48 months.

Of 276 non-industry observational studies under Postoperative Complications, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 39. This study's 48 months is above that.

Counting every sponsor, half of 281 studies reached it within 22 months; a quarter within 10 and three quarters within 39.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 24, 2021
First posted
Mar 1, 2021
StartActual
Mar 1, 2021
Primary completionActual
Mar 30, 2025
CompletionActual
Apr 15, 2025
Last update
Jul 7, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04774354
Lead sponsor
Ángel Becerra-Bolaños, MD PhD
Responsible party
Ángel Becerra-Bolaños, MD PhD (Principal Investigator, Hospital Universitario de Gran Canaria Doctor Negrín) — Sponsor-investigator
First posted
Mar 1, 2021
Start date
Mar 1, 2021
Primary completion
Mar 30, 2025
Completion
Apr 15, 2025
Last update
Jul 7, 2026

Study contacts

Ángel Becerra, MD PhD
principal investigator · Hospital Universitario de Gran Canaria Doctor Negrín

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion